In the BioHarmony Drug Report Database

"Preview" Icon

Atosiban

Tractocile (atosiban) is a protein pharmaceutical. Atosiban was first approved as Tractocile on 2000-01-20. It has been approved in Europe to treat premature birth. It is known to target vasopressin V1b receptor, vasopressin V1a receptor, oxytocin receptor, and vasopressin V2 receptor.

 

Trade Name

 

Tractocile
 

Common Name

 

atosiban
 

ChEMBL ID

 

CHEMBL382301
 

Indication

 

premature birth
 

Drug Class

 

Oxytocin antagonists

Image (chem structure or protein)

Atosiban structure rendering